RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

Excellent example--another surrogate marker being used as a shortcut to quasi-POC.
This is an option for Cortex on their own, I have no idea which marker (PET or EEG) would be considered more substantive. The best surrogate marker (at least from a market perspective) is beta-amyloid load, but there's no reason to expect that to change with CX701.

NeuroInvestment